文章
醫療新知 > Coca-Cola May Soon Be Used In Cancer Medication?

Coca-Cola May Soon Be Used In Cancer Medication?

19-03-2016

 曾否幻想過汽水, 糖果, 零食能夠治療疾病



根據德國Erasmus MC 癌症臨床研究中心發表,酸性飲料有助於提供肺癌標靶藥物Tarceva在胃裡的理想環境,提升藥物的療效。
由於肺癌標靶藥物Tarceva的有效性及吸收與胃中的酸鹼度PH值相關,而常與Tarceva一起服用的質子幫浦抑制劑(PPI),會大量提升胃中的PH值成強鹼度,將影響標靶藥物的吸收達61%
研究中,肺癌病患在服用標靶藥物及PPI藥物(Nexium)時,同時喝可口可樂時,Tarceva的吸收率大量的提升,也讓治療效果更好。
研究醫師說,可口可樂是一種強酸的飲料,病患一次服用250ml是可容許的範圍


吃標靶藥配可口可樂,會變成標配嗎?!!

(鳴謝 : 台灣全癌症病友連線  )

 

—————————————————————————————————


Coca-Cola
 may play an important role in the absorption of a lung cancer medication, as claimed by some scientists from Erasmus MC Cancer Institute in Rotterdam, the Netherlands.

Coca-Cola Classic, to be precise, is being seen as the acidic beverage that could help create the ideal environment in the stomach for the lung cancer drug Tarceva (erlotinib) to be more effectively absorbed.

According to the Dutch scientists, the absorption and effectiveness of Tarceva is reliant on the pH levels in the stomach. However, certain proton pump inhibitors (PPIs) that are prescribed with the cancer drug tend to raise the pH in the stomach to high alkalinity.

The raised alkalinity lowers the absorption of Tarceva by almost 61% eventually cutting down its effectiveness.

 

Coca-Cola used to increase acidity

Researcher  Dr. Roelof van Leeuwen, says that he wondered if the pH could be reversed and environment in stomach made more conducive by taking Tarceva with the cola beverage as the latter is acidic.

As part of his study, he observed the effect of the combination on 28 volunteers and found that the patients taking Nexium (a PPI) with Tarceva when administered the dose along with Coca-Cola Classic in a set order, could absorb the medication better.

“Cola intake led to a clinically relevant and statistically significant increase” in Tarceva absorption, said the research team in the online Journal of Clinical Oncology.

The researchers are of the opinion that drinking half-a-can of Cola while taking Tarceva could improve the effectiveness of the medication.

“Unfortunately, many patients requiring Tarceva also need proton pump inhibitors to decrease stomach acidity caused by gastritis” — an irritation of the stomach lining — or by the drugs they are taking, such as certain painkillers, said Dr. Alan Mensch of Northwell Health’s Plainview Hospital, in Plainview, N.Y.

“The result is less stomach acid and less absorption of Tarceva, making the drug less effective in treating the cancer,” he explained.

The scientists explained that Coca-Cola was a choice because it was the most acidic of the beverages. Besides, the patients too felt that 250 ml of the beverage was well-tolerated.

The research may open up new arenas of effectiveness of cancer drugs in other cancers as well.

Read more: http://www.healthaim.com/coca-cola-may-soon-used-cancer-medication/40647#ixzz43Ivwtku9

城中活動

2022-12-15 11:00 上午 花藝班聖誕篇
2022-12-15 9:30 上午 中國傳統文化導賞團

疑難排解

會員註冊


或許你會想看
慢性淋巴細胞白血病 (CLL) 口服標靶藥 助病人長時間穩定病情
王紹明醫生 中文大學內科及藥物治療學系名譽臨床副教授 「慢性淋巴細胞白血病 (Chronic lymphocy […]
中大全球首證血糖波動不穩的肥胖型糖尿病患者有較高患癌風險 並證實接受一類常用降血壓藥物的糖尿病患者患癌風險則較低
香港中文大學(中大)醫學院利用大數據研究糖尿病患者的患癌風險,首次獲得兩項重要發現。研究團隊發現患有糖尿病並有 […]
中大葉氏家族基金腫瘤學教授陳林教授就職演講「不苦口的良藥」
抗癌治療的副作用為患者帶來巨大的生理和心理壓力,肝膽胰癌症患者更經常因器官受損,比其他癌症患者較易出現相關副作 […]
中大與國際團隊領導肺癌研究 證實Lorlatinib可成為ALK陽性晚期非小細胞肺癌一線治療
香港中文大學(中大)醫學院莫樹錦教授與國際肺癌專家團隊早前針對帶有「間變性淋巴瘤激酶(ALK)基因變異」的晚期 […]
中大研發嶄新治療組合 帶領亞洲策略性抗擊膽管癌
中大研發嶄新治療組合 帶領亞洲策略性抗擊膽管癌 2022年8月8日 1 中大醫學院領導的一項多中心臨床研究發現 […]
新藥Dostarlimab給MMR缺損病人的新希望
新藥Dostarlimab給MMR缺損病人的新希望 [醫療新資訊] MMR缺損對人們有甚麼影響呢﹖為甚麼新藥D […]
【創新科研】中大研新型抗癌免疫療法及可彎曲手術鑽 全國挑戰杯共奪5獎
【創新科研】中大研新型抗癌免疫療法及可彎曲手術鑽 全國挑戰杯共奪5獎 ▲ 左起:病理解剖及細胞學系助理教授鄧銘 […]
芯片上的蠕蟲能視作癌症偵察器﹖
芯片上的蠕蟲能視作癌症偵察器﹖ [癌症資訊新聞] 根據《科學報告》學術期刊發表了一篇研究報告指,科學家利用秀麗 […]
基石藥業胃腸道間質瘤精準靶向藥(avapritinib)在香港正式上市 創新療法有望惠及更多患者
基石藥業胃腸道間質瘤精準靶向藥(avapritinib)在香港正式上市 創新療法有望惠及更多患者   在眾多癌 […]